Boothbay Fund Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Buy |
+12,100
| New | +$665K | 0.01% | 642 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1495 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1536 |
|
|
2023
Q2 | – | Sell |
-25,781
| Closed | -$2.51M | – | 1603 |
|
|
2023
Q1 | $2.51M | Buy |
25,781
+19,019
| +281% | +$1.85M | 0.05% | 464 |
|
|
2022
Q4 | $700K | Buy |
6,762
+1,941
| +40% | +$201K | 0.02% | 860 |
|
|
2022
Q3 | $409K | Sell |
4,821
-7,343
| -60% | -$623K | 0.01% | 1159 |
|
|
2022
Q2 | $1.01M | Buy |
12,164
+6,034
| +98% | +$500K | 0.03% | 711 |
|
|
2022
Q1 | $473K | Sell |
6,130
-3,973
| -39% | -$307K | 0.01% | 1044 |
|
|
2021
Q4 | $893K | Buy |
+10,103
| New | +$893K | 0.02% | 686 |
|
|
2021
Q2 | – | Sell |
-12,152
| Closed | -$918K | – | 1682 |
|
|
2021
Q1 | $918K | Buy |
+12,152
| New | +$918K | 0.03% | 517 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 927 |
|
|
2020
Q2 | – | Sell |
-7,980
| Closed | -$674K | – | 840 |
|
|
2020
Q1 | $674K | Buy |
+7,980
| New | +$674K | 0.06% | 335 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 682 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 651 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 659 |
|
|
2017
Q2 | – | Sell |
-5,575
| Closed | -$489K | – | 592 |
|
|
2017
Q1 | $489K | Buy |
+5,575
| New | +$489K | 0.09% | 214 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 467 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 288 |
|